Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17396300 | 0.98 | MEN1 (0.40) | MEN1CYP1A2KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL12568711 | 0.89 | MEN1 (0.33) | MEN1CYP1A2KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL12568721 | 0.85 | MEN1 (0.30) | MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL12568720 | 0.83 | LMNA (0.34) | LMNA | |
| SCHEMBL19562998 | 0.82 | MEN1 (0.40) | MEN1CYP1A2KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL12568694 | 0.82 | MEN1 (0.40) | MEN1CYP1A2KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL12568698 | 0.82 | MEN1 (0.40) | MEN1CYP1A2KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL12568678 | 0.80 | MEN1 (0.39) | MEN1CYP1A2KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL17210863 | 0.79 | EPHX2 (0.32) | MEN1CYP1A2KMT2ASMN1; SMN2LMNA | |
| SCHEMBL6896590 | 0.79 | KMT2A (0.41) | KMT2ASMN1; SMN2TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224574-A1 | COATED NONWOVEN POROUS ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-30 | — | — | WO | claimed |
| CN-105106176-A | Degradable organic silicon nanocapsule drug carrier as well as preparation method and application thereof | UNIV WUHAN | 2015-12-02 | — | — | CN | claimed |
| US-12600130-B2 | Ejection head nozzle flooding control | BRADY WORLDWIDE, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-12590180-B2 | Olefinic compositions comprising hydrocarbon resins | ExxonMobil Product Solutions Company (US) | 2026-03-31 | — | — | US | disclosed |
| US-12583222-B2 | Solvent compatible nozzle plate | BRADY WORLDWIDE, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| EP-4674624-A1 | NOZZLE PLATE, FLUID EJECTION HEAD, FLUID EJECTION DEVICE, AND MODIFYING METHOD OF NOZZLE PLATE | Brady Worldwide, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| US-20250381557-A1 | IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-12-18 | — | — | US | disclosed |
| WO-2025224574-A1 | COATED NONWOVEN POROUS ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20250136744-A1 | HYBRID OLEFINIC COMPOSITIONS COMPRISING RESIN COMPOSITIONS POLYMERIZABLE BY ADDITION OR CONDENSATION POLYMERIZATION REACTIONS | ExxonMobil Product Solutions Company | 2025-05-01 | — | — | US | disclosed |
| EP-4545543-A1 | IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-04-30 | — | — | EP | disclosed |
| US-12247134-B2 | Coating compositions | MATERIA, INC. (US) | 2025-03-11 | — | — | US | disclosed |
| WO-2015094938-A1 | LAMINATED ARTICLES FOR MICROBIAL REMOVAL AND LOW PRESSURE DROP FILTRATION, METHODS OF MAKING, AND METHODS OF USING SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015047464-A1 | GUANIDINE-FUNCTIONALIZED METAL SILICATE PARTICLES AND METHODS OF MAKING AND USING SUCH PARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-04-02 | — | — | WO | disclosed |
| WO-2015047464-A1 | GUANIDINE-FUNCTIONALIZED METAL SILICATE PARTICLES AND METHODS OF MAKING AND USING SUCH PARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-04-02 | — | — | WO | disclosed |
| WO-2014088807-A1 | GUANIDINE-FUNCTIONALIZED PARTICLES AND METHODS OF MAKING AND USING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014088807-A1 | GUANIDINE-FUNCTIONALIZED PARTICLES AND METHODS OF MAKING AND USING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-12 | — | — | WO | disclosed |
| US-7959992-B2 | Porous inkjet recording material comprising a silane coupling agent | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2011-06-14 | — | — | US | disclosed |
| US-20080008882-A1 | Porous inkjet recording material | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-01-10 | — | — | US | disclosed |
| US-6057377-A | FORMING A SOLUTION OF SOL-GEL MATERIAL IN SOLVENT, IMPRINTING MOLECULE AND A FUNCTIONALIZING SILOXANE MONOMER, EVAPORATING SOLVENT AND REMOVING IMPRINTING MOLECULE | SANDIA CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0104875-B1 | PROCESS FOR THE PRODUCTION OF FORMATES | BP Chemicals Limited (GB) | 1985-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590180-B2 | Olefinic compositions comprising hydrocarbon resins | RAD51, COG2, HRH2 | MEN1 4276/4885CYP1A2 869/4885KMT2A 1165/4885 |
| US-12583222-B2 | Solvent compatible nozzle plate | HTR3D, HTR3E, NEFM | MEN1 208/4885CYP1A2 1492/4885KMT2A 3192/4885 |
| US-20250381557-A1 | IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME | CA2, GRIA1, GUCY1A2 | MEN1 1684/4885CYP1A2 2515/4885KMT2A 736/4885 |
| US-12600130-B2 | Ejection head nozzle flooding control | AQP4, DSG1, WFS1 | MEN1 603/4885CYP1A2 3988/4885KMT2A 3936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.